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Impact of biofeedback-induced cardiovascular stability on he- tolerance to hemodialysis and the possibility of main-
modialysis tolerance and efficiency. taining adequate dry body weight [13]. At the same time,
Background. Hypotension is caused by a drop in blood vol- studies on urea kinetics have demonstrated the impor-ume during ultrafiltration, followed by vasoconstriction and
tance of solute volume distribution calculation and possi-reduced perfusion in some regions of the body.
ble double-pool effects [14–17]. It has been frequentlyMethods. We carried out a prospective controlled crossover
study on 12 hypotension-prone patients with two different mo- observed that solute mass recovered in the spent dialy-
dalities: (A) acetate-free hemodiafiltration with standard ultra- sate is smaller than that one could expect based on
filtration control, and (B) acetate-free hemodiafiltration with changes of blood concentration in the patient. This phe-monitoring of blood volume and automatic biofeedback with
nomenon has been attributed to an apparent distributionmachine-driven adjustments on ultrafiltration and dialysate
volume for urea that is smaller than real [17–19]. Sinceconductivity. We measured urea Kt/V and equilibrated Kt/V
(eKt/V), urea rebound, and urea removal. Hypotensive epi- transcellular equilibration for urea is almost instanta-
sodes and interventions were recorded. neous, it seems that intracellular trapping of urea is un-
Results. In group B, fewer hypotensive episodes were re- likely to be the primary factor involved in this phenome-corded (24 out of 72 in group B vs. 59 out of 72 in group A).
non. Thus, this observation seems to depend on a verySaline infusion was required in 57 cases in group A and 15
efficient solute removal from a smaller portion of thecases in group B. Urea Kt/V was 1.34 6 0.08 in group A and
was 1.26 6 0.06 in group B; eKt/V was much higher in group whole distribution volume deriving from an altered
B (1.12 6 0.05) than in group A (1.03 6 008). A significantly blood flow distribution in several regions of the body
higher rebound was observed in group A (14.2 6 2.7%) com- [20–29]. As a final consequence, postdialytic rebound ofpared with group B (6.4 6 2.3%).
urea concentration takes place depending on the equili-Discussion. A greater solute sequestration seems to occur
during hemodialysis with hypotension. This results in lower bration of urea between the sequestrated pool and the
eKt/V, enhanced postdialytic rebound, and lower solute re- effectively dialyzed pool.
moval. Higher efficiency can be observed when dialysis is car- This mechanism may limit the efficiency of the treat-
ried out smoothly and cardiovascular stability is maintained.
ment with an importance proportional to the size of theWe conclude that new systems for blood volume monitoring
sequestrated pool. It has been suggested that vasocon-and automatic biofeedback may not only reduce the number
of hypotensive episodes during dialysis, but may also contribute striction caused by hemodialysis and ultrafiltration may
to significantly increase the efficacy of the treatment. be the key factor in reducing the perfusion of some
regions of the body where urea can therefore be seques-
trated. Thus, an intracorporeal recirculation of dialyzed
The ultimate goal of hemodialysis treatment is to blood takes place in a central vascular loop, while periph-
achieve the highest level of efficiency in the presence eral regions remain poorly perfused with a progressive
of maximal clinical tolerance [1–12]. In recent years, discrepancy between the content of urea in the two pools.
reduced treatment times have resulted in higher ultrafil- Under these circumstances, hypotension may further af-
tration rates, thus enhancing the problems of patient fect tissue perfusion because of compensatory vasocon-
striction. In a previous article, we observed that hypoten-
sion-prone patients present high urea rebound and lowerKey words: ultrafiltration, blood volume, adequate dialysis, dry body
weight, vasoconstriction, equilibrated Kt/V, chronic hemodialysis. equilibrated Kt/V [13]. From this viewpoint, efficiency
of hemodialysis and clinical tolerance appear to be linkedReceived for publication October 6, 1999
by a common denominator, which is tissue perfusion andand in revised form February 4, 2000
Accepted for publication February 21, 2000 vascular stability.
Intradialytic hypotension has been correlated with theÓ 2000 by the International Society of Nephrology
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rate of ultrafiltration and relative blood volume (BV) correction of buffer balance by postdilutional infusion
of bicarbonate-based replacement solution [35].changes [30]. The reduction of circulating BV (DBV)
depends on the discrepancy between the ultrafiltration
Treatment schedulesrate and intravascular refilling rate [31, 32]. Today, there
Schedule A was as follows: acetate-free biofiltration,is the possibility of monitoring online relative BV
blood flow of 350 mL/min, dialysate flow of 500 mL/changes using several methods, such as light absorption
min, using an automatic ultrafiltration control systemor scattering. Despite a large variability, most patients
and manual adjustment of ultrafiltration rate if requireddisplay a threshold for BV reduction; beyond this value,
throughout the session. Schedule B was as follows: ace-there is a high chance of hypotension. The curve of BV
tate-free biofiltration carried out with the same parame-change may be used in an integrated system to drive the
ters plus a biofeedback-driven automatic adjustment ofrate of ultrafiltration during treatment in the attempt
ultrafiltration rate and dialysate conductivity (Hemocon-to prevent hypotension. Further improvements may be
trole, Hospal, Mirandola, Italy).obtained if a variable sodium concentration is applied
The scheduled time for both sessions was 220 6 5to the dialysis solution [33, 34].
minutes. Each patient was studied for four weeks. EachBased on these premises, we may hypothesize that
treatment schedule was carried out for two weeks (6hemodialysis carried out with “guided” ultrafiltration
sessions) and the, AB – BA sequence was randomizedprofile and variable dialysate sodium (driven by DBV)
in each patient.may not only result in better clinical tolerance but also
in a higher treatment efficiency. The last effect should Measurements
be caused by a reduced solute compartmentalization and
Urea concentration was measured in blood before, ata reduced rebound effect.
the end, and after 30 minutes from the end of the session.The aim of our present study was to evaluate the
Single-pool Kt/V, postdialytic rebound, equilibratedimpact on vascular stability and treatment efficiency of
Kt/V, and urea mass removed were calculated using thea new biofeedback system characterized by online BV
formulas reported in the literature [29]. Urea mass re-control through instantaneous corrections of ultrafiltra-
moved was measured by continuous partial collection oftion rate and dialysate conductivity (DC). For this pur-
spent dialysate with a specifically designed device [Quan-pose, a series of hemodialysis sessions carried out with
tiscane (QTSC), Hospal, Mirandola, Italy]. In the firstand without a biofeedback loop was compared in the
30 sessions, a parallel measurement was performed bysame chronic hemodialysis patients.
total collection of spent dialysate [direct dialysate quanti-
fication (DDQ)] to obtain a validation of the QTSC
method.METHODS
Study design Recruitment and clinical assessments
This was a prospective, randomized, crossover study Preliminary assessment was done with bioelectrical
carried out on 12 hypotension-prone patients (8 males impedance to ensure an adequate patient hydration sta-
and 4 females) for a total of 144 hemodialysis sessions tus. Once the hydration parameters resulted within nor-
that used either standard controls (schedule A) or a mal values, the patient was recruited for the study after
biofeedback system (schedule B). obtaining informed consent. The study was also licensed
by the local ethical committee.Population
Hypotension episodes, symptoms, and medical or
Patients were on hemodialysis for more than six nursing interventions during each hemodialysis session
months at the beginning of the study, and all had a well- were carefully recorded. Effective treatment duration
functioning internal arteriovenous (AV) fistula. Their and total weight loss were also recorded. Hypotension
ages were between 35 and 72 years, and body weights was defined by a drop in systolic blood pressure of
varied from 45 to 94 kg. All of them were recruited on the greater than 40 mm Hg from the starting value or by a
basis of the clinical history recorded over the previous lower drop in the presence of symptoms. We reported
month. The selection criteria were the following: pres- the number of dialysis sessions with hypotension over
ence of symptomatic hypotension in more than 70% of the total number of dialysis sessions analyzed. Dialysis
the last 12 sessions, interdialytic weight gain greater than with hypotension was considered in those sessions in
3 kg, and normal hydration status as determined by a which at least one episode of hypotension was detected.
bioelectrical impedance analysis. All of the patients were
Study end pointstreated with acetate-free biofiltration, one of the most
sophisticated types of hemodiafiltration, characterized The end points of the study were the following: (1)
difference in cardiovascular stability measured by theby the absence of acetate in the dialysate and a complete
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Fig. 1. Schematic representation of the sys-
tem for partial dialysate collection. A continu-
ous proportional spilling is made from the line
of the spent dialysate. The quantity is regu-
lated by a pump, and it is scaled down from
the spent dialysate flow, which includes the
amount of ultrafiltration. The system can col-
lect a fraction of the total spent dialysate flow.
In such a manner, the collected liquid will be
representative of the whole, thus giving the
physician the possibility to make any sort of
analysis.
number of intradialytic hypotension episodes, symptoms, and collection time (CT), and transfers the information
or medical-nursing intervention; and (2) differences in on the machine’s screen. Solute concentration (SC) can
urea kinetics measured by single-pool Kt/V, postdialytic be measured in the collected fluid (mmol/L), allowing
rebound, equilibrated Kt/V, and urea mass removed. the calculation of solute mass removed (SC 3 WDV,
Paired t-test, linear regression test, and the Bland Alt- mmol).
man test were used to analyze the obtained data. Our study used the system in an automatic mode: The
sampling pump automatically ran to obtain the represen-
Technological details tative sample of the waste dialysate considering the set-
Continuous partial collection of dialysate. The system tings of the treatment and any subsequent variations in
utilized in the study is designed to collect a fraction the scheduled parameters, including dialysate bypass,
of the total spent dialysate. The proportional sample alarms, and others.
collected permits calculation of the total amount of spent Biofeedback system. This system is a software loop
dialysate and its average solute concentration. Thus, to- designed to actuate a biofeedback response based on
tal solute removal can be calculated without the need to signals derived online from the patient/machine com-
collect enormous amounts of fluid. plex. The integrated multi-input-multi-output controller
The system is composed of a sampling peristaltic and its software are the heart of this biofeedback system.
pump, fully integrated into the machine, that draws a The main targets that are involved are weight loss, equiv-
fraction of spent dialysate at a very low flow rate [in alent conductivity and DBV. The monitored discrepanc-
accordance with the dialysate flow rate, weight loss rate ies between the instantaneous value and the instanta-
(WLR), and infusion flow rate settings] into a plastic neous target for BV change, conductivity, and weight
bag (Fig. 1). During the collection, the sampling flow loss represent the input parameters for the controller.
(Qs) is computed by the following formula: The control variables utilized as outputs parameters are
the dialysate conductivity (DC) and weight loss rate
Qs 5 K * (Qd 1 Quf 1 Qd)
(WLR; Fig. 2).
Starting from the integrated monitoring of BV, basedwhere K is a coefficient in accordance to the dialysate
on an optical absorption biosensor (Hemoscane; Hos-flow rate (at 500 mL/min K 5 1/1000).
pal, Mirandola, Modena), the system can read and man-The functioning principle is based on the high stability
age this physiological parameter, as it is linked to theand accuracy achieved by the flow control system on the
removed water and to the physiological refilling of thedialysis machine and on the stability of the sampling
patient.peristaltic pump over a dialysis treatment period. The
After a learning phase for any single patient to under-system maintains its accuracy with dialysate flow rates
stand the standard morphology of the BV curve, thebetween 350 and 1000 mL/min. Dialysate flow rate and
target for this parameter can be set from the beginningQs stability are guaranteed by the manufacturers with a
of the session, and be included in the prescription of thevariability of less than 1%.
The system measures waste dialysate volume (WDV) treatment.
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Fig. 2. Schematic representation of the multi-input–multi-output control system that characterizes the biofeedback loop. Starting from an integrated
monitoring of BV, based on a optical absorption biosensor, the system can read and manage this physiological parameter, linked to the removed
water and to the physiological refilling of the patient, that is known as one of the most important in the genesis of the intradialytic hypotension.
This means that after a learning phase for any patient of the BV curve, it is possible to find a target for this parameter and include it in the initial
prescription of the treatment. Beyond the weight loss target and the equivalent conductivity (Na) target, we have now the BV target that will be
managed through a closed loop system. The integrated multi-input–multi-output controller and software are the heart of this biofeedback system:
It can accept different monitored variables like inputs (in this case 3) and can have different control variables like outputs, in this case 2, DC and
WLR. The goal of this biofeedback management is to reach the best compromise among the multiple targets of the treatment.
Hence, besides the target weight loss and the target Starting from the numeric values of each target given
equivalent conductivity (that is, the desired sodium con- as an input, the system automatically designs the trajec-
centration at the end of the session), the target BV can tory for each single target, considering the range of toler-
be prescribed. This is managed through the closed-loop ance. In detail, by combining the WL and the BV trajec-
biofeedback system. tory in a bidimensional domain, a graphic description
The goal of biofeedback management is to reach the of the instantaneous condition of the treatment can be
best compromise among the various targets, considering obtained, which illuminates whether the prescribed tar-
that these target values (given as inputs) can be in conflict gets will be reached (Fig. 3). At the same time, the graph
one against the others. To correct a large BV change, shows the distance to reaching the target values and how
one solution could be to reduce WLR, but this cannot be the initial prescription can be modified to achieve each
done below certain limits without indefinitely prolonging goal. All of these graphs and information are displayed
the duration of the session. On the other hand, increasing on the machine monitor (Fig. 4).
the dialysate sodium in an attempt to obtain higher refill-
ing rates is also limited by physiological ranges and the
RESULTSconsequent sense of thirst of the patient.
In the presence of similar ultrafiltration rates and re-Within the operative logic of the artificial kidney, the
quired weight losses, the cardiovascular tolerance wasthree main parameters (BV, plasma sodium, and weight
significantly improved in the biofeedback-driven ses-loss) are driven through a precise curve during the treat-
sions. In particular, the number of hypotension episodesment aiming at the best compromise among the three
was significantly lower with the biofeedback system, andtargets; this operation is performed with a given range
the symptoms were markedly reduced even in the caseof tolerance for each parameter. This is a safety feature
of hypotension. In Table 1, the hemodialysis parametersof the monitor that reacts with specific alarms and infor-
relevant to ultrafiltration and the clinical parameters per-mation to the operator when the prescribed compromise
cannot be achieved. taining to the cardiovascular response to ultrafiltration
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Fig. 3. Starting from the numeric target that we give like input, the system automatically designs the trajectory for each single target, considering
also the tolerance. Combining the WL and the BV trajectory, we can observe during the session a kind of cruciform graph inside which the graphic
bullet tells whether the final target can be reached and how far we are from it. To drive the BV, the machine controls minute by minute the two
control variables that are the WLR and the conductivity.
are reported for the two modes of dialysis. Because the associated with a significantly higher equilibrated Kt/V
in the sessions carried out with biofeedback. Therefore,target of the system is to provide a hypotension-free
dialysis session, the results are reported describing the despite an apparently higher efficiency in the manually
controlled sessions (group A), the real efficiency wasnumber of sessions with clinically relevant hypotension
compared with the total number of studied dialysis ses- superior in the biofeedback-driven sessions (group B).
The explanation of this observation lies in the artificiallysions. It should be emphasized that the overall weight
loss and the rate of ultrafiltration did not differ between small urea distribution volume observed in sessions with
hypotension. As the blood purification process couldthe two dialysis modes. In contrast, the number of hypo-
tensive episodes decreased significantly with the use of only have access to a reduced volume, urea remained
sequestrated in high concentrations in peripheral re-biofeedback. A general well-being was recorded in ses-
sions carried out with biofeedback, and surprisingly, gions. As a result, urea concentrations fell remarkably
during treatment, but a significant rebound was observedeven in the presence of hypotension, the patients dis-
played a reduced symptomatology and required less in the minutes following the end of the session. This
phenomenon can explain the results obtained in termsmedical or nursing intervention. These results are proba-
bly correlated with a progressive correction of the BV of urea removal in the two groups of sessions. Solute
removal results from the product (clearance 3 concen-variations by an immediate variation in the rate of ultra-
filtration and DC in the biofeedback-driven sessions. tration). In the presence of similar clearances but differ-
ent apparent distribution volumes, the amount of soluteThis, in turn, may result in a less dramatic alteration of
the intravascular filling pressure and permitted easier removed will be lower in the treatment in which blood
concentration displays a greater reduction.adaptations of the vascular tone to such conditions.
The effects of the achieved cardiovascular stability In our study, total urea removed in the two groups
was significantly different (Table 2). The accuracy ofwere paralleled by an improved efficiency of treatment.
A lower rebound was observed in the biofeedback ses- total removal measured by partial dialysate collection
(QTSC) was demonstrated by its high coefficient of cor-sions, resulting in a higher equilibrated Kt/V. In Table
2, the urea kinetic parameters are displayed for the two relation (r 5 0.982, P , 0.0001) with the measure ob-
tained by total dialysate collection (DDQ). The statisti-dialysis modes. Single-pool Kt/V was higher in the ses-
sions carried out with the standard controls. At the same cal comparison of the two methods, carried out with the
Bland Altman test, is reported in Figure 5.time, probably because of the high frequency and the
severity of hypotension, postdialytic rebound for urea Instantaneous urea clearance measured in the two di-
alysis modes did not differ significantly, with an averagewas also higher in this dialysis mode. These data were
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Fig. 4. An example of two typical screens dur-
ing a biofeedback guided hemodialysis session.
In the top panel, the detailed trajectory for
BV and WL and the curve of WLR and con-
ductivity show how the system works in rela-
tionship to the relative tolerances and limits.
In the bottom panel, numerical and graphical
representations give practical and clinical in-
formation on the screen about the parameters
involved in the biofeedback loop.
value of 200 6 18 mL/min in group A and 204 6 19
Table 1. Cardiovascular tolerance mL/min in group B. The predialysis urea concentrations
were almost identical for each patient in the studiedStandard Biofeedback P
sessions with the two dialysis modes (90 6 18 mg/dL inWeight loss/session g 36466684 37106710 NS
group A and 91 6 20 mg/dL in group B). These dataUltrafiltration rate mL/min 16.663.6 16.963.7 NS
Hypotension episodes 59/72 24/72 ,0.001 suggest that differences in total solute removal are only
Presence of symptoms 55/72 15/72 ,0.001 due to a different profile of solute concentration in theInterventions/infusions 57/72 15/72 ,0.001
blood during the treatment. The removal values were
also normalized by the amount of solute present in the
body at the beginning of the session. The resulting values
calculated in a weekly period (solute removal index)
Table 2. Urea kinetics were significantly higher in the biofeedback-driven ses-
sions.Standard Biodfeedback P
Single pool Kt/V 1.3460.08 1.2660.06 ,0.005
Equilibrated Kt/V 1.0360.08 1.1260.05 ,0.001 DISCUSSION
Urea rebound % 14.262.7 6.462.3 ,0.001
Urea removal g 30.464.1 35.463.7 ,0.005 The primary goal of hemodialysis is to achieve an
Solute removal index 1.7760.15 2.0160.23 ,0.005 adequate blood purification and dry weight control with
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which is designed a priori and is based on physiological
assumptions. The requirement for online monitoring of
physiological signals soon became evident [38–44].
During dialysis, patient assessment is normally limited
to occasional measurements of body weight and blood
pressure, with therapeutic intervention only upon the
appearance of symptoms or side effects. A more percep-
tive patient monitoring from a biochemical and physical
standpoint might enable the early recognition of signs
of intolerance and might permit an early intervention.
Today, online monitoring is possible for different para-
meters, such as conductivity, urea kinetics, BV changes,
thermal balance, and access recirculation [45, 46].
For some time, online monitoring devices had been
considered mere toys for advanced research rather than
Fig. 5. Quantiscan measure of urea mass removal versus direct dialy- real tools for routine clinical application. Today, several
sate quantitation (total dialysate collection). Comparison of the two
of these new devices are increasingly displaying theirmethods is shown.
clinical utility. At the same time, the advances in technol-
ogy permit a reduction in the cost of these important
and sophisticated accessories. It seems, therefore, that a
the highest degree of clinical tolerance and patient well- new generation of dialysis machines will be incorporating
being. In the past, these two aspects were frequently different sensors and online monitoring devices. The sub-
considered separate and independent variables. In our sequent step is the generation of a smart dialysis machine
article, we suggest that cardiovascular stability and treat- able to mimic what happens in nature where rapid feed-
ment efficiency can, at least to a certain extent, be defi- back occurs in response to physiologic signals. With this
nitely linked. perspective, an automatic biofeedback loop has been
Two events have modified the scenario of dialysis ther- proposed to improve dialysis tolerance [47]. In an at-
apy over the past decade: the progressive increase in tempt to prevent the occurrence of dialysis hypotension,
the population of aged patients with concurrent morbid signals such as BV changes and conductivity measures
conditions (such as cardiovascular diseases, diabetes, have been integrated in a multi-input controller capable
etc.), and the substantial increase in dialysis efficiency of providing, via software, a series of output signals that
and efficacy [36, 37]. These two events are neither easy result in variations of the treatment parameters. Correc-
to reconcile, nor are they compatible. Aged and critically tions are practically effected by changes in the rate of
ill patients are unstable and prone to dialysis-related ultrafiltration and in the dialysate inlet conductivity. In-
cardiovascular intolerance. On the other hand, high- stead of waiting for a manual feedback operated by the
efficiency dialysis, particularly if associated with short nurse, the multi-input–multi-output controller tends to
treatment times, is more unsettling and less well toler- reach the selected target of intradialytic weight loss and
ated compared with less aggressive therapies. maximal tolerance by a continuous compromise between
All of these phenomena, together with the understand- ultrafiltration, conductivity, and actual weight loss. This
ing that each patient may present specific requirements article presents our experience with this type of auto-
and needs, suggested the prescription of an individual- matic biofeedback in multiple sessions.
ized hemodialysis treatment. In several cases, however, The present study demonstrates the efficacy of a bio-
treatment personalization was not sufficient to achieve feedback system in reducing the rate of intradialytic hy-
satisfactory results, and further technological advance- potension in hypotension-prone patients. Even in the
ments had to be planned. Starting from this requirement, presence of hypotension, patients experienced remark-
the concept of treatment profiling emerged in the dialysis able well-being and fewer symptoms in sessions carried
scenario. Patients may undergo physiological variations out with biofeedback. Improved cardiovascular stability
during the treatment, and the dialytic parameters set at has a positive impact on urea kinetics and treatment
the beginning of the session may not be adequate after a efficiency. In particular, because of a reduced solute com-
few hours of therapy. Hence, specific software programs partmentalization and a better blood flow distribution
have been designed to preset variable profiles of ultrafil- within the body, urea rebound is reduced, and equili-
tration and dialysate sodium concentration. Very soon, brated Kt/V is improved. At similar levels of predialysis
however, this approach displayed its limits, and the suc- urea concentration and fluid gain, the amount of urea
cess was lower than expected. The limit of treatment removed is increased because of a steadier blood concen-
tration throughout the session. Blood temperature wasprofiling in fact lies in the blind nature of the prescription,
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